Hormone Replacement Therapy in Menopause: A Comprehensive Review
DOI:
https://doi.org/10.12775/JEHS.2025.86.66897Keywords
Menopause, Hormone Replacement Therapy, estrogens, progestogens, bone healthAbstract
Menopause is a natural, physiological milestone in a woman's life. It is defined by the permanent end of menstruation, which follows the depletion of ovarian follicles and a decline in estrogen and inhibin levels. This hormonal transition can give rise to numerous symptoms, including hot flashes, night sweats, mood swings, sleep disturbances, vaginal dryness, and decreased libido. These symptoms can significantly impair quality of life. Hormone therapy (HT) is the most effective treatment for alleviating vasomotor and genitourinary symptoms, and it offers protective benefits for bone health by reducing the risk of osteoporosis. However, HT is also associated with an increased risk of venous thromboembolism and certain hormone-dependent cancers, such as breast and endometrial cancer. Therefore, careful evaluation is necessary before initiating treatment. Emerging evidence highlights the positive effects of non-hormonal strategies, such as physical activity and diets rich in phytoestrogens. These strategies may serve as alternatives to or complements of HT for managing menopausal symptoms. Ultimately, treatment plans must be tailored to each woman's symptoms, health status, and preferences to optimize therapeutic outcomes and improve quality of life during menopause.
References
[1] Peacock, K., Carlson, K., & Ketvertis, K. M. (2023). Menopause. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK507826/
[2] Faubion, S. S., Crandall, C. J., Davis, L., el Khoudary, S. R., Hodis, H. N., Lobo, R. A., Maki, P. M., Manson, J. A. E., Pinkerton, J. A. v., Santoro, N. F., Shifren, J. L., Shufelt, C. L., Thurston, R. C., & Wolfman, W. (2022). The 2022 hormone therapy position statement of The North American Menopause Society. Menopause, 29(7), 767–794. https://doi.org/10.1097/GME.0000000000002028
[3] Pinkerton, J. v. (2020). Hormone Therapy for Postmenopausal Women. New England Journal of Medicine, 382(5), 446–455. https://doi.org/10.1056/nejmcp1714787
[4]Santen, R. J., Allred, D. C., Ardoin, S. P., Archer, D. F., Boyd, N., Braunstein, G. D., Burger, H. G., Colditz, G. A., Davis, S. R., Gambacciani, M., Gower, B. A., Henderson, V. W., Jarjour, W. N., Karas, R. H., Kleerekoper, M., Lobo, R. A., Manson, J. A. E., Marsden, J., Martin, K. A., … Utian, W. H. (2010). Postmenopausal hormone therapy: An endocrine society scientific statement. Journal of Clinical Endocrinology and Metabolism, 95(7), s1–s66. https://doi.org/10.1210/jc.2009-2509
[5] Johansson, T., Karlsson, T., Bliuc, D., Schmitz, D., Ek, W. E., Skalkidou, A., Center, J. R., & Johansson, Å. (2024). Contemporary menopausal hormone therapy and risk of cardiovascular disease: Swedish nationwide register based emulated target trial. The BMJ, 387, e078784. https://doi.org/10.1136/BMJ-2023-078784
[6]Faubion, S. S., Crandall, C. J., Davis, L., el Khoudary, S. R., Hodis, H. N., Lobo, R. A., Maki, P. M., Manson, J. A. E., Pinkerton, J. A. v., Santoro, N. F., Shifren, J. L., Shufelt, C. L., Thurston, R. C., & Wolfman, W. (2022). The 2022 hormone therapy position statement of The North American Menopause Society. Menopause, 29(7), 767–794. https://doi.org/10.1097/GME.0000000000002028
[7]Burger, H. G., Hale, G. E., Robertson, D. M., & Dennerstein, L. (2007). A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women’s Midlife Health Project. Human Reproduction Update, 13(6), 559–565. https://doi.org/10.1093/HUMUPD/DMM020
[8]Davis, S. R., Lambrinoudaki, I., Lumsden, M., Mishra, G. D., Pal, L., Rees, M., Santoro, N., & Simoncini, T. (2015). Menopause. Nature Reviews. Disease Primers, 1. https://doi.org/10.1038/NRDP.2015.4
[9]Delamater, L., & Santoro, N. (2018). Management of the Perimenopause. Clinical Obstetrics and Gynecology, 61(3), 419–432. https://doi.org/10.1097/GRF.0000000000000389
[10]Nelson, H. D. (2008). Menopause. Lancet (London, England), 371(9614), 760–770. https://doi.org/10.1016/S0140-6736(08)60346-3
[11]Burger, H. G. (1996). The endocrinology of the menopause. Maturitas, 23(2), 129–136. https://doi.org/10.1016/0378-5122(95)00969-8
[12] Broekmans, F. J., Soules, M. R., & Fauser, B. C. (2009). Ovarian aging: mechanisms and clinical consequences. Endocrine Reviews, 30(5), 465–493. https://doi.org/10.1210/ER.2009-0006
[13]Goldštajn, M. Š., Mikuš, M., Ferrari, F. A., Bosco, M., Uccella, S., Noventa, M., Török, P., Terzic, S., Laganà, A. S., & Garzon, S. (2022). Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic review. Archives of Gynecology and Obstetrics, 307(6), 1727. https://doi.org/10.1007/S00404-022-06647-5
[14] Bennett, S., & Mathur, R. (2024). Hormone Replacement Therapy. Obstetrics, Gynaecology and Reproductive Medicine, 34(3), 58–65. https://doi.org/10.1016/j.ogrm.2023.12.002
[15]Mehta, J., Kling, J. M., & Manson, J. A. E. (2021). Risks, Benefits, and Treatment Modalities of Menopausal Hormone Therapy: Current Concepts. Frontiers in Endocrinology, 12, 564781. https://doi.org/10.3389/FENDO.2021.564781
[16]Harper-Harrison G, Carlson K, Shanahan MM. Hormone Replacement Therapy. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Jul 1]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK493191/
[17] Cho, L., Kaunitz, A. M., Faubion, S. S., Hayes, S. N., Lau, E. S., Pristera, N., Scott, N., Shifren, J. L., Shufelt, C. L., Stuenkel, C. A., & Lindley, K. J. (2023). Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long? Circulation, 147(7), 597–610. https://doi.org/10.1161/CIRCULATIONAHA.122.061559
[18]Henderson, V. W., & Lobo, R. A. (2012). Hormone therapy and the risk of stroke: perspectives ten years after the Women’s Health Initiative trials. Climacteric : The Journal of the International Menopause Society, 15(3), 229. https://doi.org/10.3109/13697137.2012.656254
[19]Tempfer, C. B., Hilal, Z., Kern, P., Juhasz-Boess, I., & Rezniczek, G. A. (2020). Menopausal Hormone Therapy and Risk of Endometrial Cancer: A Systematic Review. Cancers, 12(8), 2195. https://doi.org/10.3390/CANCERS12082195
[20]Micha, J. P., Rettenmaier, M. A., Bohart, R. D., & Goldstein, B. H. (2022). Hormone Therapy and Risk of Breast Cancer: Where Are We Now? Journal of Menopausal Medicine, 28(2), 47. https://doi.org/10.6118/JMM.21035
[21]Bansal, R., & Aggarwal, N. (2019). Menopausal Hot Flashes: A Concise Review. Journal of Mid-Life Health, 10(1), 6. https://doi.org/10.4103/JMH.JMH_7_19
[22]Lorentzon, M., Johansson, H., Harvey, N. C., Liu, E., Vandenput, L., Crandall, C. J., Cauley, J. A., LeBoff, M. S., McCloskey, E. v., & Kanis, J. A. (2022). Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability—results from the Women’s Health Initiative hormone therapy trials. Osteoporosis International, 33(11), 2297. https://doi.org/10.1007/S00198-022-06483-Y
[23]Silva, A. S. da, Baines, G., Araklitis, G., Robinson, D., & Cardozo, L. (2021). Modern management of genitourinary syndrome of menopause. Faculty Reviews, 10, 25. https://doi.org/10.12703/R/10-25
[24]Humphries, K. H., & Gill, S. (2003). Risks and benefits of hormone replacement therapy: The evidence speaks. CMAJ: Canadian Medical Association Journal, 168(8), 1001. https://pmc.ncbi.nlm.nih.gov/articles/PMC152685/
[25] Menopause, A. C. of the K. S. of, Lee, S. R., Cho, M. K., Cho, Y. J., Chun, S., Hong, S.-H., Hwang, K. R., Jeon, G.-H., Joo, J. K., Kim, S. K., Lee, D. O., Lee, D.-Y., Lee, E. S., Song, J. Y., Yi, K. W., Yun, B. H., Shin, J.-H., Chae, H. D., & Kim, T. (2020). The 2020 Menopausal Hormone Therapy Guidelines. Journal of Menopausal Medicine, 26(2), 69. https://doi.org/10.6118/JMM.20000
[26] Khan, S. J., Kapoor, E., Faubion, S. S., & Kling, J. M. (2023). Vasomotor Symptoms During Menopause: A Practical Guide on Current Treatments and Future Perspectives. International Journal of Women’s Health, 15, 273. https://doi.org/10.2147/IJWH.S365808
[27] Lee, H., Caguicla, J. M. C., Park, S., Kwak, D. J., Won, D.-Y., Park, Y., Kim, J., & Kim, M. (2016). Effects of 8-week Pilates exercise program on menopausal symptoms and lumbar strength and flexibility in postmenopausal women. Journal of Exercise Rehabilitation, 12(3), 247. https://doi.org/10.12965/JER.1632630.315
[28] Aarshageetha, P., Rani Janci, P. R., & Devi Tharani, N. (2023). Role of Alternate Therapies to Improve the Quality of Life in Menopausal Women: A Systematic Review. Journal of Mid-Life Health, 14(3), 153–158. https://doi.org/10.4103/JMH.JMH_222_22
[29] Stubbs, C., Mattingly, L., Crawford, S. A., Wickersham, E. A., Brockhaus, J. L., & McCarthy, L. H. (2017). Do SSRIs and SNRIs reduce the frequency and/or severity of hot flashes in menopausal women. The Journal of the Oklahoma State Medical Association, 110(5), 272. https://pmc.ncbi.nlm.nih.gov/articles/PMC5482277/
[30]Madsen, T. E., Sobel, T., Negash, S., Allen, T. S., Stefanick, M. L., Manson, J. E., & Allison, M. (2023). A Review of Hormone and Non-Hormonal Therapy Options for the Treatment of Menopause. International Journal of Women’s Health, 15, 825. https://doi.org/10.2147/IJWH.S379808
[31]Platt, O., Bateman, J., & Bakour, S. (2025). Impact of menopause hormone therapy, exercise, and their combination on bone mineral density and mental wellbeing in menopausal women: a scoping review. Frontiers in Reproductive Health, 7, 1542746. https://doi.org/10.3389/FRPH.2025.1542746
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Michalina Cyrulik, Natalia Ramlau , Dominika Kolenda, Zuzanna Fischer, Marcin Podolak, Michał Hładki, Michalina Simachi , Michalina Janiszewska, Beata Imbirska, Marta Prager-Zimny
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 7
Number of citations: 0
